1. Columbia University (18 from 2,490 patents)

2. Bristol-Myers Squibb Compnay (15 from 3,687 patents)

3. University of Washington (5 from 2,109 patents)

4. The General Hospital Corporation (4 from 2,898 patents)

5. Fred Hutchinson Cancer Center (4 from 289 patents)

6. Ariagen, Inc. (4 from 8 patents)

7. The United States of America, as Represented by the Secretary, Department of Health and Human Services (3 from 3,540 patents)

8. University of California (2 from 15,543 patents)

9. Melinta Therapeutics, Inc. (2 from 24 patents)

10. Eleusis Therapeutics US, Inc. (2 from 3 patents)

11. Science Applications International Corporation (1 from 461 patents)

12. Albany Molecular Research, Inc. (1 from 97 patents)

13. Rib-X Pharmaceuticals, Inc. (1 from 17 patents)

14. Melinta Subsidiary Corp. (13 patents)

15. Fred Hutchinson Cancer Research Center (8 patents)

1. 12473302 - 4-phenylpiperidines, their preparation and use

2. 12404277 - Substituted 4-phenylpiperidines, their preparation and use

3. 11919913 - 4-phenylpiperidines, their preparation and use

4. 11891386 - Indole compounds and their use

5. 11779573 - Crystalline forms of compounds for preventing or treating sensory hair cell death

6. 11702417 - Compounds for improving mRNA splicing

7. 11680043 - Pharmaceutically acceptable salts of psilocin and uses thereof

8. 11649240 - Substituted 4-phenylpiperidines, their preparation and use

9. 11459322 - Indole compounds and their use

10. 11427576 - Indole compounds and their use

11. 11390621 - Chiral indole compounds and their use

12. 11312684 - Pharmaceutically acceptable salts of psilocin and uses thereof

13. 11117884 - Potent gamma-secretase modulators

14. 11028098 - 4-phenylpiperidines, their preparation and use

15. 10913746 - Substituted 4-phenylpiperidines, their preparation and use